GPCA covers the latest fund, investment and industry news across our markets in two newsletters: NewsWatch is a weekly round-up of key transactions across asset classes; the Global Tech Brief is a bi-weekly review of tech transactions and innovations with cross-border applications. Subscribe in the left-hand sidebar.
Access past editions of NewsWatch here.
Glory Reaches USD120m Final Close for Second China Venture Fund
Glory Ventures has reached a USD120m final close for its second China-focused venture fund targeting investments in tech infrastructure and applications. Read More
Yingke PE Reaches ~USD1.6b Final Close for CNY Biomedicine Fund
Yingke Private Equity has reached a CNY10b (~USD1.6b) final close for its latest CNY-denominated fund targeting investments in biomedicine and hard technology sectors. Yingke PE also recently closed its third USD-denominated fund. Read More
SUSI Partners Reaches USD81m First Close for Southeast Asia Renewables Fund
SUSI Partners has reached a USD81m first close for its Asia Energy Transition Fund, a vehicle targeting investments in the renewable energy sector in Southeast Asia. The Asian Infrastructure Investment Bank contributed to the first close with a USD50m commitment. Read More
4Di Capital, Mogul Capital, Convergence Partners, Others Invest USD47m Series A for South Africa’s LifeQ
LifeQ, a South Africa-based provider of biometrics and health information derived from wearable devices, has raised a USD47m Series A from Invenfin, 4Di Capital, Allectus Capital, Mogul Capital, Tenhong Holdings, Analog Devices, Hannover Re, Convergence Partners, Stellar Capital Partners, Nedbank Corporate and Investment Bank, Delos, OneBio Seed Investment Fund, Virgin Group, Lireas, Allen & Co and Acequia Capital. Read More
CPE, Tencent and Taikang Insurance Lead USD110m Series C for Chinese Data Management Firm Xuncetech
CPE, Taikang Insurance Group and returning investor Tencent led a USD110m Series C for China-based asset data management company Xuncetech, with follow-on from Goldman Sachs and Greater Bay Area Homeland Investments. Read More
Ribbit Capital Leads USD300m Series E for Brazilian Proptech QuintoAndar
Ribbit Capital led a USD300m Series E for Brazilian proptech QuintoAndar, with participation from SoftBank LatAm Innovation Fund, LTS, Maverik, Alta Park, KASZEK, Dragoneer, Kevin Efrusy (Accel) and an undisclosed US-based asset manager, at a reported USD4b valuation. Read More
Ribbit Capital Leads USD300m Series E for Brazilian Proptech QuintoAndar
Ribbit Capital led a USD300m Series E for Brazilian proptech QuintoAndar, with participation from SoftBank LatAm Innovation Fund, LTS, Maverik, Alta Park, KASZEK, Dragoneer, Kevin Efrusy (Accel) and an undisclosed US-based asset manager, at a reported USD4b valuation. Read More
JD Logistics Raises USD3.2b via HKSE IPO
JD Logistics, the delivery arm of Chinese e-commerce giant JD.com, has raised ~USD3.2b in its Hong Kong listing. This is the largest HKSE listing in 2021 after China-based live streaming app Kuaishou raised ~USD6.2b in February. Read More
General Catalyst, DST Global and monashees Invest USD30m in Mexican Corporate Expense Startup Clara
General Catalyst, DST Global and monashees have invested USD30m in Clara, a Mexico-based startup offering corporate expense management and credit cards for Mexican startups, at a reported USD130m valuation. Clara also secured a USD50m debt facility from an undisclosed investor as part of the round. Read More
SoftBank and WeWork Announce Joint Venture in Latin America
SoftBank and WeWork have announced a joint venture that provides SoftBank Latin America Fund with the exclusive right to operate the WeWork brand in Argentina, Brazil, Chile, Colombia and Mexico. Read More
Vivo Capital and Novo Holdings Lead USD200m Series A for Singapore’s Esco Lifesciences
Vivo Capital and Novo Holdings led a USD200m Series A for Esco Lifesciences, a Singapore-based developer of cell and gene therapy tools, with participation from China Investment Corporation and EDBI. Read More
Polaris Partners Leads USD43m Series A for Singaporean Drug Discovery Platform Engine Biosciences
Polaris Partners led a USD43m Series A for Singapore-based drug discovery platform Engine Biosciences, with follow-on from 6 Dimensions Capital, WuXi AppTec, DHVC, EDBI, Baidu Ventures, Vectr Ventures, Goodman Capital, WI Harper and Nest Bio Labs. Read More